Compare · RLX vs TLRY
RLX vs TLRY
Side-by-side comparison of RLX Technology Inc. (RLX) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RLX and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RLX is the larger of the two at $2.77B, about 4.9x TLRY ($568.6M).
- TLRY has been more active in the news (15 items in the past 4 weeks vs 4 for RLX).
- TLRY has more recent analyst coverage (14 ratings vs 2 for RLX).
- Company
- RLX Technology Inc.
- Tilray Brands Inc.
- Price
- -
- -
- Market cap
- $2.77B
- $568.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 4
- 15
- Recent ratings
- 2
- 14
RLX Technology Inc.
RLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest RLX
- SEC Form 6-K filed by RLX Technology Inc.
- RLX Technology Announces Unaudited Second Quarter 2026 Financial Results
- RLX Technology to Report Second Quarter 2026 Financial Results on August 14, 2026
- SEC Form 4 filed by Chief Financial Officer Lu Chao
- SEC Form 6-K filed by RLX Technology Inc.
- RLX Technology Announces Unaudited First Quarter 2026 Financial Results
- RLX Technology to Report First Quarter 2026 Financial Results on May 20, 2026
- RLX Technology Files 2025 Annual Report on Form 20-F
- SEC Form 20-F filed by RLX Technology Inc.
- SEC Form 3 filed by new insider Wang Ying Kate
Latest TLRY
- BrewDog Wins Big at the 2026 World Beer Awards with a Sweeping Show of Brewing Excellence
- Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand
- BrewDog Unwraps Its 2026 Advent Calendar
- Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
- Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
- Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
- Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.
- Hi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership
- Breckenridge Distillery Turns Colorado’s Famous Palisade Peaches into a Fresh Pour of Summer with New Peach Whiskey
- Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities